Highlights and Quick Summary
- Equity Repurchase (Preffered, Net) for the quarter ending December 31, 2021 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Equity Repurchase (Preffered, Net) decreased by -100.0%
- Annual Equity Repurchase (Preffered, Net) for 2021 was $4.94 Million (a -92.87% decrease from previous year)
- Annual Equity Repurchase (Preffered, Net) for 2020 was $69.3 Million (a 571.45% increase from previous year)
- Twelve month Equity Repurchase (Preffered, Net) ending December 31, 2021 was $4.94 Million (a -92.9% decrease compared to previous quarter)
- Twelve month trailing Equity Repurchase (Preffered, Net) decreased by -93.25% year-over-year
Trailing Equity Repurchase (Preffered, Net) for the last four month:
| 31 Dec '21 | 30 Sep '21 | 30 Jun '21 | 31 Mar '21 |
|---|---|---|---|
| $4.94 Million | $69.7 Million | $69.7 Million | $73.3 Million |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Equity Repurchase (Preffered, Net) of Absci Corporation
Most recent Equity Repurchase (Preffered, Net)of ABSI including historical data for past 10 years.Interactive Chart of Equity Repurchase (Preffered, Net) of Absci Corporation
Absci Corporation Equity Repurchase (Preffered, Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | $0.0 | $0.0 | $0.0 | $4.94 | $4.94 |
| 2020 | $64.71 | $0.0 | $3.63 | $0.99 | $69.33 |
| 2019 | – | – | – | – | $10.33 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology